Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia

NCT02110394 · clinicaltrials.gov ↗

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

OTHER: bendamustine
OTHER: rituximab

Sponsor

Astellas Pharma Europe B.V.